Liquidia Corp (LQDA)
10.03
-0.06
(-0.59%)
USD |
NASDAQ |
Oct 04, 16:00
10.04
0.00 (0.00%)
After-Hours: 20:00
Liquidia Shareholders Equity (Annual): 47.29M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.29M |
| December 31, 2022 | 90.42M |
| December 31, 2021 | 65.26M |
| December 31, 2020 | 71.09M |
| Date | Value |
|---|---|
| December 31, 2019 | 34.95M |
| December 31, 2018 | 18.69M |
| December 31, 2017 | -33.69M |
| December 31, 2016 | -18.25M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
34.95M
Minimum
2019
90.42M
Maximum
2022
61.80M
Average
65.26M
Median
2021
Shareholders Equity (Annual) Benchmarks
| United Therapeutics Corp | 5.985B |
| Arcturus Therapeutics Holdings Inc | 278.51M |
| Paragon 28 Inc | 169.72M |
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| AIM ImmunoTech Inc | 10.23M |